Becton, Dickinson & Co. (BDX)
175.89
-1.92
(-1.08%)
USD |
NYSE |
Feb 13, 16:00
176.00
+0.11
(+0.06%)
After-Hours: 20:00
Becton, Dickinson EPS Diluted (Quarterly) : 1.336 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 1.928 |
| Abbott Laboratories | 1.017 |
| Baxter International, Inc. | 0.0175 |
| Boston Scientific Corp. | 0.4493 |
| Integra LifeSciences Holdings Corp. | -0.0704 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 382.00M |
| Revenue (Quarterly) | 5.252B |
| Total Expenses (Quarterly) | 4.87B |
| Enterprise Value | 68.54B |
| Gross Profit Margin (Quarterly) | 45.91% |
| Profit Margin (Quarterly) | 7.27% |
| Earnings Yield | 3.48% |
| Operating Earnings Yield | 6.41% |
| Normalized Earnings Yield | -0.436 |